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Epidemiology, Risk and Prognostic Factors in Mesenteric Venous
Thrombosis
Acosta S, Alhadad A, Svensson P, et al. Br J Surg 2008;95:1245-1251.
Conclusion: Mesenteric venous thrombosis (MVT) can be accurately
diagnosed with portal venous-phase computed tomography (CT) scanning,
and activated protein C resistance is associated with MVT.
Summary: The authors used an inpatient and autopsy registry to
identify patients at their hospital with MVT from 2000 to 2006. MVT was
diagnosed in 51 patients. The diagnosis was made at autopsy in six patients.
Patients aged 70 to 79 years had the highest incidence of MVT (11.3 per
100,000 person-years). Testing for activated protein C resistance was done
in 29 patients, and 13 were positive. D-dimer levels were assessed in five pa-
tients, and all had elevated D-dimer. Multidetector row CT scans were done
in the portal venous phase in 20 patients. The examination was positive in all
20 patients. There were 12 patients with surgery, with a median length of
bowel resection of 0.6 m (range, 0.1-2.2 m). The 30-day mortality for the
entire group was 20%. Increased mortality was associated with intestinal
infarction (P .046), treatment on a nonsurgical ward (P .001), and lack
of performance of CT scan (P  .022). Long-term mortality was associated
with presence of cancer, with a hazard ratio of 4.03 (95% CI, 1.03-15.85;
P  .046).
Comment:MVT, at least symptomaticMVT, occurs infrequently. The
diagnosis is difficult because symptoms are generally nonspecific. Mortality
rates can be high. The authors’ data are consistent with what one would
suspect. CT scanning with a venous phase works well for diagnosis, and
many of these patients will have a hypercoagulable state with, at least in this
study, factor V Leiden mutation identified as the most prevalent abnormal-
ity. The study highlights the current standard of care for patients with
possible MVT: a CT scan for diagnosis, anticoagulation for most patients,
bowel resection for those with peritonitis, and an aggressive evaluation for
hypercoagulable state with likely long-term anticoagulation. Long-term
prognosis is largely related to the presence of malignancy.A Prospective Study of Incidence of Saphenous Nerve Injury after
Total Great Saphenous Vein Stripping
Flu HC, Breslau PJ, Hamming JF, et al. Dermatol Surg 2008;34:1333-9.
Conclusion: There is only a minor incidence of saphenous nerve
damage after total stripping of the great saphenous vein (GSV).
Summary: Even in the era of endovenous ablation, partial stripping of
the GSV is still a treatment option for some patients with primary varicose
veins. Even with GSV reflux above and below the knee, clinicians generally
perform a partial stripping of the GSV, leaving the below knee segment in
situ because of fear of saphenous nerve injury. There are, however, very little
data on the incidence of saphenous nerve injury after total GSV.
The authors sought to evaluate the incidence of saphenous nerve
damage after total GSV stripping in patients treated for primary varicose
veins. A preoperative and postoperative neurologic examination was per-
formed independently by a neurologist, with a protocol supervised and
approved by the Department of Neurology at the authors’ hospital. Patients
were also administered a standardized questionnaire asking whether they
had experienced unpleasant or altered sensation in the leg or had discovered
areas of numbness or decreased sensation after surgery.
Total stripping of the GSV was performed in 69 limbs. Indication
for the surgery was pain in 9%, fatigue of limbs in 77%, and cosmetic
reasons in 14%.
The overall incidence of postoperative sensory neurologic deficits
was 6%, with the incidence falling to 3% after 3 months of follow-up, and
99% of patients reported a reduction in signs and symptoms of primary
varicose veins.
Comment: The study suggests it is reasonable to treat the GSV below
the knee when total saphenous reflux is present. These surgical results
parallel a similar study that used endovenous techniques to treat total GSV
reflux. It appears that when GSV reflux is present above and below the knee,
a complete treatment of the vein, whether by endovascular or open surgical
techniques, results in a very low incidence of saphenous nerve injury. There
should be a randomized trial to evaluate symptom reduction and saphenous
nerve injury in patients with total GSV reflux treated with total vs above knee
only saphenous stripping or endovenous ablation.
